One pill for HIV

HIV positive patients in the US will soon be able to take the first single-pill, once-a-day treatment.

Atripla, which has just been approved by the FDA in America, combines three drugs in a “cocktail” therapy that can be swallowed in one dose.

Their makers, Gilead, Bristol-Myers Squibb and Merck, will now try to get approval to sell the pill outside the US.